FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Lupin Pharmaceuticals Bimatoprost Ophthalmic Solution Recall

Bimatoprost Ophthalmic Solution, 0

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class III
Reported by FDA
Jan 8, 2020
Recall ID
D-0635-2020
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Bimatoprost Ophthalmic Solution starting Dec 13, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0635-2020 on Jan 8, 2020. Reason: Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

Product description

Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.

Lot numbers, UPCs & expiration codes

Lot# H801686, Exp. 12/31/2019.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0635-2020
Classification
Class III
Status
Terminated
Recall initiated
Dec 13, 2019
FDA report date
Jan 8, 2020
Quantity
2,130 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0635-2020, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
84495
Address
Harborplace Tower
Address (line 2)
111 S Calvert St Fl 21st
Code information
Lot# H801686, Exp. 12/31/2019.
Postal code
21202-6174
Report date
Jan 8, 2020
Product type
Drugs
Recall number
D-0635-2020
Classification
Class III
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
2,130 bottles
Termination date
Oct 19, 2020
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Dec 13, 2019
Initial firm notification
Letter
Center classification date
Jan 2, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0635-2020, published Jan 8, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls